These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
665 related articles for article (PubMed ID: 36830717)
21. Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy. Zhang W; Zhao Z; Li F Mol Immunol; 2022 Apr; 144():58-70. PubMed ID: 35203022 [TBL] [Abstract][Full Text] [Related]
23. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells. East JE; Sun W; Webb TJ J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308 [TBL] [Abstract][Full Text] [Related]
24. Combining radiotherapy and NK cell-based therapies: The time has come. Baude J; Limagne E; Ladjohounlou R; Mirjolet C Int Rev Cell Mol Biol; 2023; 378():31-60. PubMed ID: 37438020 [TBL] [Abstract][Full Text] [Related]
26. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy? Ben-Shmuel A; Biber G; Barda-Saad M Front Immunol; 2020; 11():275. PubMed ID: 32153582 [TBL] [Abstract][Full Text] [Related]
27. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells. Webb TJ; Bieler JG; Schneck JP; Oelke M J Immunol Methods; 2009 Jul; 346(1-2):38-44. PubMed ID: 19446558 [TBL] [Abstract][Full Text] [Related]
28. Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy. Wu Y; Li J; Jabbarzadeh Kaboli P; Shen J; Wu X; Zhao Y; Ji H; Du F; Zhou Y; Wang Y; Zhang H; Yin J; Wen Q; Cho CH; Li M; Xiao Z Pharmacol Res; 2020 May; 155():104691. PubMed ID: 32070721 [TBL] [Abstract][Full Text] [Related]
29. Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy. Shaver KA; Croom-Perez TJ; Copik AJ Front Immunol; 2021; 12():679117. PubMed ID: 33995422 [TBL] [Abstract][Full Text] [Related]
30. Spatial Organization and Prognostic Significance of NK and NKT-like Cells via Multimarker Analysis of the Colorectal Cancer Microenvironment. Väyrynen JP; Haruki K; Lau MC; Väyrynen SA; Ugai T; Akimoto N; Zhong R; Zhao M; Dias Costa A; Borowsky J; Bell P; Takashima Y; Fujiyoshi K; Arima K; Kishikawa J; Shi SS; Twombly TS; Song M; Wu K; Chan AT; Zhang X; Fuchs CS; Meyerhardt JA; Giannakis M; Ogino S; Nowak JA Cancer Immunol Res; 2022 Feb; 10(2):215-227. PubMed ID: 34937729 [TBL] [Abstract][Full Text] [Related]
31. NK and NKT cells have distinct properties and functions in cancer. Liu X; Li L; Si F; Huang L; Zhao Y; Zhang C; Hoft DF; Peng G Oncogene; 2021 Jul; 40(27):4521-4537. PubMed ID: 34120141 [TBL] [Abstract][Full Text] [Related]
32. Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy. Bollino D; Webb TJ Transl Res; 2017 Sep; 187():32-43. PubMed ID: 28651074 [TBL] [Abstract][Full Text] [Related]
33. The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma. Simon B; Wiesinger M; März J; Wistuba-Hamprecht K; Weide B; Schuler-Thurner B; Schuler G; Dörrie J; Uslu U Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103488 [TBL] [Abstract][Full Text] [Related]
34. Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions. Russick J; Joubert PE; Gillard-Bocquet M; Torset C; Meylan M; Petitprez F; Dragon-Durey MA; Marmier S; Varthaman A; Josseaume N; Germain C; Goc J; Dieu-Nosjean MC; Validire P; Fournel L; Zitvogel L; Bindea G; Lupo A; Damotte D; Alifano M; Cremer I J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067317 [TBL] [Abstract][Full Text] [Related]
35. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876 [TBL] [Abstract][Full Text] [Related]
36. Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome. Krijgsman D; Roelands J; Andersen MN; Wieringa CHLA; Tollenaar RAEM; Hendrickx W; Bedognetti D; Hokland M; Kuppen PJK Mol Immunol; 2020 Dec; 128():205-218. PubMed ID: 33142138 [TBL] [Abstract][Full Text] [Related]
37. Differential modulating effect of natural killer (NK) T cells on interferon-γ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection. Zhao L; Gao X; Peng Y; Joyee AG; Bai H; Wang S; Yang J; Zhao W; Yang X Immunology; 2011 Oct; 134(2):172-84. PubMed ID: 21896012 [TBL] [Abstract][Full Text] [Related]
38. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression. Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA Front Immunol; 2018; 9():1990. PubMed ID: 30298063 [TBL] [Abstract][Full Text] [Related]
39. Natural killer T cell deficiency in active adult-onset Still's Disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells. Lee SJ; Cho YN; Kim TJ; Park SC; Park DJ; Jin HM; Lee SS; Kee SJ; Kim N; Yoo DH; Park YW Arthritis Rheum; 2012 Sep; 64(9):2868-77. PubMed ID: 22605480 [TBL] [Abstract][Full Text] [Related]
40. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway. Hodge G; Mukaro V; Holmes M; Reynolds PN; Hodge S Respirology; 2013 Feb; 18(2):369-76. PubMed ID: 23062183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]